SUMMARY Isolated perfused kidneys removed from a rabbit 24-48 hours after renal vein constriction exhibited a markedly enhanced release of renal prostaglandins (PG's) induced by vasoactive peptides. Stimulation of the perfused renal vein-constricted kidney with 300 ng of bradykinin (BK) caused the release of 5980 ± 1409 ng of PGE 2 compared to a release of 290 ± 45 ng from the contralateral control kidney. Infusion of indomethacin abolished the PGE 2 formation (confirmed by radiochromatography) in both the renal vein-constricted and contralateral kidneys. Bradykinin and angiotensin II stimulation of the renal vein-constricted kidney (but not the contralateral kidney) also revealed the presence in the renal venous effluent of a rabbit aorta-contracting substance (RCS). Identification of the RCS as thromboxane A 2 (TxA 2 ) was confirmed by determining the biological half life (38 ± 6 sec) in comparison with standard TxA 2 (30 ± 3 sec) and PG endoperoxide (135 ± 13 sec). Incubation with [
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ROBERT ZIPSER, STUART MYERS, AND PHILIP NEEDLEMAN SUMMARY Isolated perfused kidneys removed from a rabbit 24-48 hours after renal vein constriction exhibited a markedly enhanced release of renal prostaglandins (PG's) induced by vasoactive peptides. Stimulation of the perfused renal vein-constricted kidney with 300 ng of bradykinin (BK) caused the release of 5980 ± 1409 ng of PGE 2 compared to a release of 290 ± 45 ng from the contralateral control kidney. Infusion of indomethacin abolished the PGE 2 formation (confirmed by radiochromatography) in both the renal vein-constricted and contralateral kidneys. Bradykinin and angiotensin II stimulation of the renal vein-constricted kidney (but not the contralateral kidney) also revealed the presence in the renal venous effluent of a rabbit aorta-contracting substance (RCS). Identification of the RCS as thromboxane A 2 (TxA 2 ) was confirmed by determining the biological half life (38 ± 6 sec) in comparison with standard TxA 2 (30 ± 3 sec) and PG endoperoxide (135 ± 13 sec). Incubation with [ l4 C]arachidonate of the renal vein-constricted cortical or medullary microsomes resulted in the formation of [ 14 C]-thromboxane B 2 . The renal thromboxane synthetase was inhibited by preincubation with imidazole. This study demonstrates exaggerated prostaglandin and thromboxane production by the kidney with renal vein constriction. These in vitro experiments suggest that relative changes in cortical synthesis of vasodilating PGE 2 and vasoconstricting TxA 2 may function to modulate renal vascular resistance in states of increased renal venous pressure. Circ Res 47: 231-237, 1980 THE KIDNEY is a major site for synthesis of the vasodepressor prostaglandins (PG's). Increasing evidence implicates these agents in the regulation of the renal circulation (McGiff et al., 1974) . Augmented vasodepressor PG release in response to ischemia (McGiff et al., 1970a) , vasoactive hormones (Needleman et al., 1974; McGiff et al., 1970b) , and other stimuli may initiate a reduction in renal vascular resistance. Prostaglandin E2 (PGE 2 ) is the major renal PG and exhibits these vasodepressor properties (Daniels et al., 1967) . However, the increase in vascular resistance associated with high renal perfusion has not been associated with decreased PGE 2 synthesis and, instead, may be related to synthesis of another product of arachidonate metabolism and a potent vasoconstrictor, thromboxane A 2 (TxA 2 ). Exaggerated synthesis of TxA 2 has been identified previously only in the isolated hydronephrotic kidney (HNK) of the rabbit (Morrison et al., 1978a) . Biosynthesis of both TxA 2 and PGE 2 has been identified in the renal cortex, the major site of resistance vessels (Morrison et al., 1978b; Nishikawa et al., 1977) . Thus, an interplay of these vasodepressor and vasoconstric-tor agents could mediate renal circulatory changes in a variety of disease states.
We proposed that elevations of renal venous pressure might be analogous to elevations of ureteral pressure in stimulating exaggerated PG and TxA 2 synthesis that functions to modulate renal vascular resistance. Acute elevations of renal vein pressure by venous constriction in animals have been reported to produce both increased (Haddy et al., 1958; Yashitoshi et al., 1966; Selkurt et al., 1949) and decreased (Hinshaw et al., 1963; Blake et al., 1949) renal vascular resistance. Increased intrarenal pressure did not account for the increased interstitial resistance in some of these studies (Haddy et al., 1958; Yoshitoshi et al., 1966; Selkurt et al., 1949) , and some authors postulated the presence of unidentified vasoactive hormones mediating the changes in vascular resistance (Haddy et al., 1958; Selkurt et al., 1949) . Since de novo protein synthesis may be necessary to evoke exaggerated PG and TxA 2 synthesis in kidney models (Morrison et al., 1978b) , we used a model of prolonged elevation of renal venous pressure rather than acute elevations to determine whether exaggerated PG and TxA 2 biosynthesis could mediate alterations of renal vascular resistance in this disorder.
Methods

Preparation of Renal Vein-Constricted and Hydronephrotic Kidneys
New Zealand male white rabbits, 2.3-3.0 kg in weight, were anesthetized with sodium pentobarbital (30 mg/kg, iv). The left renal vein was isolated VOL. 47, No. 2, AUGUST 1980 through a small left flank incision and partially occluded by tying a 4-0 silk suture around the vein and an adjacent polyethylene tube [(0.84-mm outer diameter), PE 100, Clay Adams, Division of Becton, Dickinson and Co.)]. After the ligature was tied, the tubing was removed, and the wound closed. The rabbits were kept in individual cages and allowed free access to food and water. Others were made hydronephrotic as described previously (Nishikawa et al., 1977) .
Kidney Perfusion
Twenty-four to 48 hours after constriction of the renal vein, the rabbits were anesthetized and treated with heparin (250 U/kg, iv). The abdominal cavity was opened and polyethylene catheters were tied into both renal arteries (PE 160, Clay Adams, Division of Becton, Dickinson and Co.). Patency of the renal vein was assessed by obstructing the renal vein adjacent to the inferior vena cava and observing blood flow after sectioning the vessel distally. The constricting suture then was removed from the renal vein-constricted kidney. The kidneys were removed, placed in warming jackets at 37°C, and perfused with oxygenated Krebs-Henseleit buffer (95% O 2 and 5% CO 2 ) at a constant rate of 12 ml/ min.
Superfused Organ System
Isolated assay tissues were superfused continuously by the renal venous effluent to monitor continuously any change from the resting basal PG levels (Ferreira and Vane, 1967) . The rat stomach and chick rectum were used to detect changes in the basal level of PGE2-like activity, and the rabbit aorta strip to detect changes in basal levels of TxA 2 -like activity. A mixture of antagonists to catecholamines, serotonin, acetylcholine, and histamine was infused directly over assay tissues to eliminate sensitivity of the assay strips to these substances (Gilmore et al., 1968) . Indomethacin (10 /xg/min) was perfused directly over the assay tissues to prevent endogenous PG release (Eckenfels and Vane, 1972) .
Bradykinin (BK) (Boehringer-Manneheim Biochemical) was prepared in a stock solution (1 mg/ ml) of saline. Appropriate dilutions were made to achieve a desired dose injected in a 0.1-ml bolus. BK was injected either into the arterial cannula (into the kidney) or directly over the assay strips (direct). Changes in smooth muscle contraction of the assay organs were measured with a Harvard transducer (Harvard Apparatus Co.).
In other studies, angiotensin II was prepared similarly and administered. For these experiments, 8-isoleucine angiotensin II or 1-sarcosine, 8-alanine angiotensin II was added to the superfusion fluid (1 /ig/min) to obviate any direct effect of angiotensin II on assay tissue contraction.
Quantification of PGE 2 by Bioassay
The renal vein effluent was collected in 50-ml samples, acidified to pH 3.5 with 1 N hydrocholoric acid, and extracted twice with an equal volume of ethyl acetate. The extract then was vacuum evaporated to dryness and reconstituted with 7.5 ml of chloroformrmethanol (2:1). This was dried under nitrogen, reconstituted with 100 niM potassium phosphate buffer (pH 8.0), and bioassayed on rat stomach strips to quantify the amount of PGE 2 -like activity present. Known PGE 2 standards were used to construct standard curves for the rat stomach tissues. Percent recovery of PGE 2 -like activity was calculated by injecting known standards of PGE 2 over the superfusion system, and acidifying, extracting, and bioassaying as described above. Measurement of BK-stimulated PGE 2 excretion was calculated as the difference of peptide-stimulated and unstimulated excretion measured immediately prior to BK administration.
Radiolabeling Infusion of Kidneys
For further identification of prostaglandins in the renal vein effluent, the renal phospholipid pool was prelabeled by infusion [
I4 C]arachidonic acid (55 mCi/mmol, Amersham/Searle Corp.), as previously described (Isakson et al., 1976) . Following BK administration, 50 ml of the venous effluent was collected, acidified to pH 3.5 with 1 N hydrochloric acid, and extracted twice in an equal volume of ethyl acetate. The extract then was vacuum evaporated to dryness and reconstituted with four drops of chloroform:methanol (2:1). Unlabeled PG standards were added to both the extract and the chromatographic plate. The extract then was chromatographed using a solvent system of benzene, 1,4-dioxane, and acetic acid (60:30:3). PG standards were visualized using iodine vapor, and the plates were analyzed in a Vangard radioisotope scanner (Packard Instrument Company).
Determination of Rabbit Aorta-Contracting Substance (RCS)-Half Time
The renal vein effluent from the perfused renal vein-constricted kidney and hydronephrotic kidney was allowed to flow directly over the rabbit aorta assay strips (zero time). The renal venous effluent then was diverted to long coils of tubing which retained the effluent for periods of 45, 90, and 150 seconds before the effluent was permitted to reach the assay tissue. The RCS produced by the kidney in response to BK was kept at 37 °C in the tubing, whereas the assay tissue was kept viable by superfusion with another source of oxygenated buffer. Each "time coil" was standardized with 250 ng of PGH 2 [prepared as previously described (Gorman et al., 1977) ] and TxA 2 [100 ng PGH 2 plus 20-jul aspirin-treated platelet microsomes at 0°C for 2 minutes ]. The rates of spontaneous, nonenzymatic hydrolysis of PGH 2 , thromboxane A 2 , and RCS following BK stimulation in the renal vein-constricted kidney and hydronephrotic kidney (known producer of TxA 2 ) were compared.
Determination of RCS Substance-Radiochemical Analysis
The renal vein-constricted and contralateral kidneys were perfused for 5 hours. The kidneys were removed and the cortex and medulla separated and weighed. The renal vein-constricted and contralateral kidneys medullas and cortices were added to three volumes (wt/vol) of oxygenated 100 HIM potassium phosphate buffer, pH 8.0, at 4°C and homogenized with a Polytron. The samples were spun at 8000 g for 15 minutes in a Sorval centrifuge at 0-5°C. The supernatant extract was removed and spun at 100,000 g for 60 minutes in a Beckman L2-75B ultracentrifuge. The microsomal pellet was resuspended in 100 HIM potassium phosphate buffer, pH 8.0, in a volume equal to one-fourth the original wet weight of tissue. Incubations of cortical and medullary microsomes were conducted in a final volume of 1 ml. Between 100 and 250 /il of cortical and medullary microsomes were used per incubation, and the remainder of the 1-ml incubation volume was made up of 100 nui potassium phosphate buffer, pH 8.0. All incubations were conducted at 37°C in the presence of 1.2 mM i-epinephrine, 1 niM reduced glutathione, and [ 14 C]arachidonic acid (300,000 count/min.), and with or without 5 mM imidazole [a known inhibitor of thromboxane synthetase ] for 60 minutes. The incubation reaction was stopped by the addition of 2 N formic acid to adjust the pH to 3.0-3.5. The samples were extracted twice in two volumes of ethyl acetate and centrifuged at 1000 g for 2 minutes. The supernatant was collected and dried under nitrogen and reconstituted with four drops of chloroform rmethanol (2:1). Authentic unlabeled PG standards and microsome extracts were run on each thin layer chromatographic plate, and plates were chromatographed in benzene, 1,4-dioxane, and acetic acid (60:30:3). The PG standards were visualized using iodine vapor, and the plates were analyzed in a Vangard radioisotope scanner (Packard Instrument Company). The radioactive peaks were scraped and counted in a liquid scintillation cocktail, using a Beckman radioisotope counter (Beckman Scientific Instruments Division). Results are expressed as mean ± SE. Statistical significance was determined by Student's £-test.
Results
Bioassay of PCs
The isolated perfused kidney removed from the rabbit after 24-48 hours of renal vein constriction exhibited a markedly enhanced basal (unstimulated by peptide) PGE 2 -like substance release as compared to release from the contralateral kidney over a 6-hour period of perfusion. Basal PGE 2 -like activity from the contralateral kidney increased from 20 ± 5 ng at 1 hour to 76 ± 24 ng at 6 hours, whereas basal PGE2-like activity from the renal vein-constricted kidney increased from 40 ± 8 ng at 1 hour to 466 ± 208 ng at 6 hours (P < 0.001 for renal veinconstricted vs. contralateral kidneys at each hourly interval, n = 5). The renal vein-constricted and contralateral kidneys were stimulated each hour with 300 ng of BK over the 6-hour period of perfusion. Hormone-stimulated PGE 2 -like activity in the contralateral kidney increased from 47 ± 8 ng at 1 hour to 248 ± 45 ng at 6 hours; for the renal veinconstricted kidney, values ranged from 192 ± 78 ng at 1 hour of perfusion to 5980 ± 1409 ng at 6 hours (P < 0.001 for the renal vein-constricted kidney vs. contralateral kidney at each hourly interval) (Fig.  1) . Between 5 and 6 hours of perfusion dose-response curves of BK were obtained from both the renal vein-constricted and contralateral kidneys ( Table 1 ). The renal vein-constricted kidney again showed a marked supersensitivity to BK stimulation as compared to the contralateral kidney. The contralateral kidney release of PGE 2 -like activity was identical to that reported for normal kidneys using identical perfusion, collection, and bioassay techniques (Morrison et al., 1978a) . Indomethacin, an inhibitor of cyclooxygenase (Vane, 1971 ), infused at a final concentration of 1 jug/ml in the perfusion media, reduced biosynthesis of PGE 2 -like activity in the renal vein-constricted kidney by 99% and in (Fig. 2) .
Identification of RCS-Bioassay Data
During the course of the bioassay for PGE 2 , a marked release of rabbit aorta-contracting substance was noted following BK administration. In the renal vein-constricted kidney, the RCS was present at 2 hours of perfusion and increased steadily through the 6th hourly stimulation with 300 ng of BK. Infusion of indomethacin completely abolished the RCS. No RCS was demonstrated even after 6 hours of perfusion in the contralateral kidney (see Fig. 3 ).
Identification of RCS-Half-Time Studies
The renal vein-constricted kidney released RCS with a half-time of loss of biological activity of 38 ± 6 seconds. The RCS half-time was not different from that released from the hydronephrotic kidney (42 ± 8) or from authentic TxA 2 (30 ± 3). Prostaglandin endoperoxide (PGH 2 ) half-time was significantly greater than all three of the others (135 ± 13 seconds, P < 0.01) (see Table 2 ).
Identification of RCS-Microsomal Study
Both cortical and medullary microsome incubations of the renal vein-constricted kidney produced thromboxane B2 (TxB 2 ) (the stable metabolite of TxA 2 ). The percentage conversion of [ 14 C]arachidonic acid to labeled PG products in the renal veinconstricted kidney medulla was 83.5 ± 2%. The percentage converted to TxA 2 was 6.2 ± 1.5%. In- 
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Comparison of the BK dose-response curve for release of PGE 2 -like activity in the RVC kidney and CLK. Each kidney was perfused for 6 hours. Dose-response curves for the RVC kidney and CLK were performed between hours 5 and 6. The PGEVlike activity was determined from doseresponse curves for standard doses of PGE2 using the rat stomach strip. The PGE2-like activity is expressed as ng PGEj-like activity per 50 ml renal venous effluent and represents the mean ± SE; n designates the number of kidneys used. cubation with 5 rriM imidazole decreased conversion to TxB 2 to 1.3%. The renal vein-constricted kidney cortex incubated with [ M C]arachidonic acid demonstrated a 62.5% conversion to labeled PG products, and conversion to TxB 2 was 12.2 ± 2.7%. Again, incubation with imidazole decreased conversion to TxA 2 to 1.7 ± 0.3% (n = 4) (see Fig. 4 ). The radiochemical data thus support the half-time data that identify the RCS produced by the renal veinconstricted kidney as TxA2. Incubation of microsomes from the contralateral kidney failed to produce any detectable TxB2.
Angiotensin II Administration
To determine whether PGE 2 release was hypersensitive to angiotensin II also, six additional contralateral and renal vein-constricted kidneys were studied. Administration of angiotensin II (300 ng) at about the 5th hour of perfusion resulted in 2670 ± 500 ng of PGE 2 from the renal vein-constricted kidney and 290 ± 70 ng from the contralateral kidney (P < 0.05). A marked release of RCS followed angiotensin administration to the renal veinconstricted but not from the contralateral kidneys.
Discussion
These studies demonstrate that renal vein constriction enhances basal and hormone-stimulated PG release. BK causes a 25-fold greater release of a prostaglandin E-like substance in the renal veinconstricted kidney than in the contralateral kidney, shifting the dose-response curve markedly to the left ( Fig. 1; Table 1 ). PG release in response to fixed doses of hormones as well as unstimulated PG release increased progressively with increasing time of perfusion in the renal vein-constricted kidney, but PG release showed only a minimal time-dependent increase in the contralateral kidney. Since PG's are not stored, the renal vein-constricted kidney must have increased de novo biosynthesis with time of perfusion. Similar studies in the kidney with ureteral obstruction have demonstrated that reversible inhibition of protein synthesis with cycloheximide and actinomycin D blocks the time-dependent increase in hormone sensitivity (Morrison et al., 1978b) .
The kidney has the potential to synthesize several vasoactive prostaglandins including PGF 2a , PGD 2 , and PGI 2 (Nishikawa et al., 1977; Needleman et al., 1978; Lee et al., 1967) , although early studies suggested that PGE 2 was the major vasodepressor Determination of the rate of spontaneous nonenzymatic hydrolysis of RCS from the renal vein-constricted (RVC) kidney following BK stimulation. The rate of spontaneous, nonenzymatic, hydrolysis of the RCS from the renal vein-constricted kidney was compared to that of the RCS from the model of 72-hr ureteral obstruction (HNK, a known producer of TxA 2 ). Each kidney is perfused with gassed (95% O 2 , 5% CO 2 ) KrebsHenseleit medium at 12 ml/min. TxA 2 control was generated by incubation of PGH 2 and aspirin-treated platelet microsomei (APM)[ * Denotes significance of P < 0.001 compared to the endoperoxide, PGH 2 . (Lee et al., 1967) . Bioassay showed that the renal vein-constricted kidney produced massive amounts (6 jug/stimulation) of PGE 2 -like substance. By prelabeling the kidney with [ H C]arachidonic acid and chromatographing the renal vein effluents, we identified [
H C]PGE 2 as the major product released after hormone stimulation (Fig. 2) . Thin layer chromatography with two different solvent systems failed to identify a major presence of the other vasoactive prostaglandins.
Control of renal vascular resistance resides mainly in the afferent and efferent arterioles of the cortex (Thurau, 1964) . However, only 10% of renal PG synthesis occurs in the cortex of normal kidneys (Larsson and Anggard, 1973) . We find that renal vein constriction enhances exaggerated renal PGE 2 synthesis; comparison of renal vein-constricted and contralateral kidney cortical microsome incubations demonstrates substantial renal vein-constricted cortical PG biosynthesis, a situation analogous to that obtained with kidneys with ureteral obstruction (Morrison et al., 1978a) . The renal veinconstricted kidney is also similar to the ureteralobstructed kidney in the hypersensitivity of PGE 2 and thromboxane A 2 release to BK and angiotensin II stimulation. Thus, cortical PG synthesis may be readily inducible in renal pathological situations.
Several studies have attempted to determine the effects of increased renal vein pressure on renal resistance by impeding renal venous flow in either in situ or isolated perfused models. In the isolated dog kidney during constant renal blood flow, Haddy et al. (1958) and Yoshitoshi et al. (1966) observed an increase in renal resistance as a result of increased renal vein pressure that was not fully explained by increased interstitial pressure. Haddy et al. (1958) suggested that renal nerves may mediate some of the increased resistance. Hinshaw et al. (1963) and others (Blade et al., 1949 ) used similar models with both intact and denervated kidneys and found a reduction in perfusion pressure. Abe et al. (1973) found no change in overall renal blood flow or resistance, but documented alterations in regional blood flow distribution. No readily apparent differences in experimental technique explain these differing observations during acute increases in canine renal venous pressure. Our study used chronic renal vein constriction of 24-48 hours prior to removal and perfusion of the kidney. Since de novo enzyme synthesis probably is required to unmask the enhanced PG and TxA 2 production, the discrepancies in the acute studies may reflect in part insufficient time for stimulation of new protein synthesis. However, the discrepancies in the acute studies may be the result of a relative excess or deficiency of the vasoconstricting TxA 2 and vasodilating PGE 2 .
Experimental evidence from isolated Krebs-perfused rabbit kidneys that PGE 2 and TxA 2 mediate changes in perfusion pressure does not necessarily imply that they are physiological mediators in the intact animal. Our studies used renal vein constriction for 24-48 hours followed by in vitro perfusion for several more hours to demonstrate the changes in PGE 2 and TxA 2 . However, our studies give insight into the factors that may stimulate renal PGE 2 and thromboxane synthesis. It is likely that the increased renal venous pressure is the stimulus, as other in vivo manipulations of the renal vascular such as renal artery constriction fail to produce similar changes (unpublished observations). Thus, prolonged increases in renal venous pressure may lead to increased synthesis of the enzymes that regulate cortical PGE 2 and TxA 2 synthesis, which may then alter renal blood flow. Consistent with this theory are observations that chronic disorders associated with increased renal venous pressure such as chronic congestive heart failure (Maxwell et al., 1950) and cirrhosis with ascites (Epstein et al., 1970) also are associated with decreased renal blood flow, although it has not been established whether the increased renal venous pressure or the variable decrease in renal artery pressure is the primary stimulus. The role of PG's and thromboxanes as mediators of vascular resistance in these states must await further in vivo studies.
